Erythropoiesis stimulating agents will bear stricter labeling.
Erythropoiesis stimulating agents (ESAs) will bear stricter labeling and will require the distribution of a Medication Guide, following new requirements set down by the Food & Drug Administration. Among the changes are the following:
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.